Literature DB >> 10022455

Reduced retinal vascularization in children with growth hormone deficiency.

A Hellström1, E Svensson, B Carlsson, A Niklasson, K Albertsson-Wikland.   

Abstract

The neovascularization in diabetic retinopathy is believed to involve locally produced angiogenic factors. In addition, there are indications that GH may influence retinal vascularization. To investigate the role of GH in retinal vascularization, we examined the retinal vascular pattern in children with congenital GH deficiency. Retinal vessel morphology was evaluated by digital image analysis of ocular fundus photographs in 39 children (5 girls and 34 boys, aged 3.6-18.7 yr) with congenital GH deficiency, and it was compared to that of 100 healthy controls. Twenty children had received GH treatment (0.1 IU/kg daily). All children were born at term, and none of the children had any clinical signs of ocular disease or reduced vision. Children with GH insufficiencies, regardless of whether they were treated with GH, had a significantly lower number of vascular branching points than the reference group (P < 0.0001). Thirty-three percent of the GH-insufficient individuals had a number of vascular branching points less than or equal to the fifth percentile of the reference group. The reduced retinal vascularization observed in children with congenital GH deficiency suggests that GH may be of importance for angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022455     DOI: 10.1210/jcem.84.2.5484

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

2.  Retina ganglion cell/inner plexiform layer and peripapillary nerve fiber layer thickness in patients with acromegaly.

Authors:  Muhammed Şahin; Alparslan Şahin; Faruk Kılınç; Harun Yüksel; Zeynep Gürsel Özkurt; Fatih Mehmet Türkcü; Zafer Pekkolay; Hikmet Soylu; İhsan Çaça
Journal:  Int Ophthalmol       Date:  2016-08-04       Impact factor: 2.031

3.  Choroidal thickness measurements in children with isolated growth hormone deficiency.

Authors:  N G Yalcin; Z Aktas; O Yuce; G D G Ikiz; M Hasanreisoglu; A Bideci
Journal:  Eye (Lond)       Date:  2017-09-15       Impact factor: 3.775

4.  Elevated intraocular pressure in patients with acromegaly.

Authors:  Luciano Quaranta; Ivano Riva; Gherardo Mazziotti; Teresa Porcelli; Irene Floriani; Andreas Katsanos; Andrea Giustina; Anastasios G P Konstas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-10       Impact factor: 3.117

5.  Evaluation of central corneal and central retinal thicknesses and intraocular pressure in acromegaly patients.

Authors:  Sefika Burcak Polat; Nagihan Ugurlu; Reyhan Ersoy; Oguzhan Oguz; Necati Duru; Bekir Cakir
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

6.  Growth hormone localization in the neural retina and retinal pigmented epithelium of embryonic chicks.

Authors:  Steve Harvey; Mia Kakebeeke; Esmond J Sanders
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 7.  The syndrome of optic nerve hypoplasia.

Authors:  Mark Borchert; Pamela Garcia-Filion
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

8.  Choroidal neovascularization in patient undergoing growth hormone treatment.

Authors:  João R de Oliveira Dias; Eduardo B Rodrigues; Maurício Martinazzo; Michel E Farah
Journal:  Clin Ophthalmol       Date:  2009-06-02

9.  Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy.

Authors:  Menaka C Thounaojam; Folami L Powell; Sagar Patel; Diana R Gutsaeva; Amany Tawfik; Sylvia B Smith; Julian Nussbaum; Norman L Block; Pamela M Martin; Andrew V Schally; Manuela Bartoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-27       Impact factor: 12.779

10.  Maternal administration of anti-angiogenic agents, TNP-470 and Angiostatin4.5, induces fetal microphthalmia.

Authors:  Catrin S Rutland; Keyi Jiang; Gerald A Soff; Christopher A Mitchell
Journal:  Mol Vis       Date:  2009-06-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.